Copyright
©The Author(s) 2025.
World J Diabetes. Jun 15, 2025; 16(6): 105711
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.105711
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.105711
Figure 2 Common signaling pathways affecting apoptosis: Phosphatidylinositol 3-kinases/protein kinase B/mammalian target of rapamycin signaling pathway and wnt/β-catenin signaling pathway.
PI3K: Phosphatidylinositol 3-kinases; AKT: Protein kinase B; mToR: Mammalian target of rapamycin; GSK-3β: Glycogen synthase kinase-3β; Cyto C: Cytochrome C; APC: Adenomatous polyposis coli gene protein; CK1: Casein kinase 1; Dvl: Dishevelled; TCF: The nuclear T cell factor; LEF: Lymphoid enhancer binding factor. It was drawn using Figdraw software.
- Citation: Nie P, Qin W, Nie WC, Li B. Progress in the application of mesenchymal stem cells to attenuate apoptosis in diabetic kidney disease. World J Diabetes 2025; 16(6): 105711
- URL: https://www.wjgnet.com/1948-9358/full/v16/i6/105711.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i6.105711